CK Life Sciences Int'l., (Holdings) Inc. (0775.HK)
HKD 0.76
(-1.3%)
HKD 0.76
(-1.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.32 Billion | 5.27 Billion | 5.4 Billion | 4.94 Billion | 4.96 Billion | 5.23 Billion |
| Cost of Revenue | 4.37 Billion | 3.64 Billion | 3.77 Billion | 3.53 Billion | 3.36 Billion | 3.49 Billion |
| Gross Profit | 947.7 Million | 1.62 Billion | 1.62 Billion | 1.4 Billion | 1.6 Billion | 1.73 Billion |
| Operating Expenses | 739.25 Million | 1.38 Billion | 685.85 Million | 647.79 Million | 650.04 Million | 584.6 Million |
| Selling, General and Administrative Expenses | 593.38 Million | 138.07 Million | 553.16 Million | 538.97 Million | 1.1 Billion | 1.24 Billion |
| Research and Development Expenses | 145.87 Million | 158.53 Million | 157.26 Million | 149.77 Million | 122.28 Million | 151.83 Million |
| Other Expenses | - | 1.24 Billion | 685.85 Million | 647.79 Million | 650.04 Million | -774.93 Million |
| Cost and Expenses | 4.42 Billion | 5.03 Billion | 4.45 Billion | 4.18 Billion | 4.01 Billion | 4.08 Billion |
| Operating Income | 897.95 Million | 339.62 Million | 336.06 Million | 247.85 Million | 376.31 Million | 555.67 Million |
| Interest Expense | 322.42 Million | 163.09 Million | 97.82 Million | 128.72 Million | 158.88 Million | 129.67 Million |
| Income Tax Expense | 51.33 Million | 72.91 Million | 75.43 Million | -6.1 Million | 27.47 Million | 120.53 Million |
| Earnings before Tax | 68.58 Million | 204.86 Million | 238.23 Million | 119.12 Million | 217.43 Million | 421.22 Million |
| Net Income | 17.25 Million | 131.96 Million | 162.8 Million | 125.23 Million | 181.73 Million | 263 Million |
| Earnings Per Share Basic | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 | 0.03 |
| Earnings Per Share Diluted | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 | 0.03 |
| Weighted Average Shares Outstanding | 9.61 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion |
| Weighted Average Shares Outstanding (Diluted) | 9.61 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion |
| Gross Margin | 0.18 | 0.31 | 0.30 | 0.28 | 0.32 | 0.33 |
| EBIT Margin | 0.09 | 0.11 | 0.11 | 0.09 | 0.12 | 0.13 |
| Profit Margin | 0.00 | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 |
| EBITDA | 486.79 Million | 469.5 Million | 449.14 Million | 353.61 Million | 475.21 Million | 521.02 Million |
| Earnings Before Tax Margin | 0.17 | 0.06 | 0.06 | 0.05 | 0.08 | 0.11 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 2.63 Billion | 2.74 Billion | 5.32 Billion | 2.57 Billion | 2.73 Billion | 5.27 Billion |
| Cost of Revenue | 1.83 Billion | 2.25 Billion | 4.37 Billion | 2.12 Billion | 2.2 Billion | 3.64 Billion |
| Gross Profit | 799.43 Million | 491.52 Million | 947.7 Million | 456.18 Million | 533.39 Million | 1.62 Billion |
| Operating Expenses | 391 Million | 391.54 Million | 724.54 Million | 332.31 Million | 425.21 Million | 1.38 Billion |
| Selling, General and Administrative Expenses | 318.09 Million | 316.59 Million | - | 261.38 Million | 325.44 Million | - |
| Research and Development Expenses | 72.9 Million | 74.94 Million | - | 70.93 Million | 99.76 Million | - |
| Other Expenses | - | - | 32.2 Million | - | - | 1.24 Billion |
| Cost and Expenses | 2.22 Billion | 2.64 Billion | 5.09 Billion | 2.45 Billion | 2.62 Billion | 5.03 Billion |
| Operating Income | 408.43 Million | 99.98 Million | 223.16 Million | 123.86 Million | 108.18 Million | 339.62 Million |
| Interest Expense | 169.53 Million | 180.73 Million | 322.42 Million | 141.68 Million | 110.89 Million | 163.09 Million |
| Income Tax Expense | 3.99 Million | 31.39 Million | 51.33 Million | 19.93 Million | 31.92 Million | 72.91 Million |
| Earnings before Tax | 4.99 Million | 11.48 Million | 68.25 Million | 56.76 Million | 99.22 Million | 204.86 Million |
| Net Income | 1 Million | -19.66 Million | 17.25 Million | 36.91 Million | 66.84 Million | 131.96 Million |
| Earnings Per Share Basic | 0.00 | -0.00 | - | 0.00 | 0.01 | - |
| Earnings Per Share Diluted | 0.00 | -0.00 | - | 0.00 | 0.01 | - |
| Weighted Average Shares Outstanding | 9.62 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion |
| Weighted Average Shares Outstanding (Diluted) | 9.61 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion | 9.61 Billion |
| Gross Margin | 0.30 | 0.18 | 0.18 | 0.18 | 0.20 | 0.31 |
| EBIT Margin | 0.09 | 0.05 | - | 0.07 | 0.06 | - |
| Profit Margin | 0.00 | -0.01 | 0.00 | 0.01 | 0.02 | 0.03 |
| EBITDA | 234.24 Million | 147.76 Million | - | 172.2 Million | 158.08 Million | - |
| Earnings Before Tax Margin | 0.15 | 0.04 | 0.04 | 0.05 | 0.04 | 0.06 |
1950
CEINSYSTECH
3052
7765
NEELKANTH
CBWTF